Laporan Laba Rugi (TTM)
Laporan Laba Rugi Immuno-Biological Laboratories Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 593 | 601 | 602 | 611 | 608 | 636 | 647 | 678 | 687 | 753 | 794 | 815 | 866 | 788 | 816 | 868 | 895 | 948 | 969 | 951 |
| Change (%) | 1.35 | 0.17 | 1.50 | -0.49 | 4.61 | 1.73 | 4.79 | 1.33 | 9.61 | 5.44 | 2.64 | 6.26 | -9.01 | 3.55 | 6.37 | 3.11 | 5.92 | 2.22 | -1.86 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 361 | 350 | 256 | 257 | 263 | 266 | 271 | 271 | 262 | 262 | 268 | 282 | 298 | 299 | 300 | 301 | 315 | 318 | 335 | 320 |
| Change (%) | -3.05 | -26.86 | 0.39 | 2.33 | 1.14 | 1.88 | 0.00 | -3.32 | 0.00 | 2.29 | 5.22 | 5.67 | 0.34 | 0.33 | 0.33 | 4.65 | 0.95 | 5.35 | -4.48 | |
| % of Revenue | 60.88 | 58.24 | 42.52 | 42.06 | 43.26 | 41.82 | 41.89 | 39.97 | 38.14 | 34.79 | 33.75 | 34.60 | 34.41 | 37.94 | 36.76 | 34.68 | 35.20 | 33.54 | 34.57 | 33.65 |
| Gross Operating Profit | 232 | 251 | 346 | 354 | 345 | 370 | 376 | 407 | 425 | 491 | 526 | 533 | 568 | 489 | 516 | 567 | 580 | 630 | 634 | 631 |
| Change (%) | 8.19 | 37.85 | 2.31 | -2.54 | 7.25 | 1.62 | 8.24 | 4.42 | 15.53 | 7.13 | 1.33 | 6.57 | -13.91 | 5.52 | 9.88 | 2.29 | 8.62 | 0.63 | -0.47 | |
| % of Revenue | 39.12 | 41.76 | 57.48 | 57.94 | 56.74 | 58.18 | 58.11 | 60.03 | 61.86 | 65.21 | 66.25 | 65.40 | 65.59 | 62.06 | 63.24 | 65.32 | 64.80 | 66.46 | 65.43 | 66.35 |
| SG&A | 478 | 461 | 320 | 300 | 278 | 249 | 310 | 282 | 276 | 271 | 295 | 280 | 262 | 259 | 276 | 282 | 293 | 282 | 300 | 295 |
| Change (%) | -3.56 | -30.59 | -6.25 | -7.33 | -10.43 | 24.50 | -9.03 | -2.13 | -1.81 | 8.86 | -5.08 | -6.43 | -1.15 | 6.56 | 2.17 | 3.90 | -3.75 | 6.38 | -1.67 | |
| % of Revenue | 80.61 | 76.71 | 53.16 | 49.10 | 45.72 | 39.15 | 47.91 | 41.59 | 40.17 | 35.99 | 37.15 | 34.36 | 30.25 | 32.87 | 33.82 | 32.49 | 32.74 | 29.75 | 30.96 | 31.02 |
| R&D | 318 | 318 | 267 | 267 | 267 | 267 | 188 | 188 | 188 | 188 | 179 | 179 | 179 | 179 | 129 | 129 | 129 | 129 | 119 | 119 |
| Change (%) | 0.00 | -16.04 | 0.00 | 0.00 | 0.00 | -29.59 | 0.00 | 0.00 | 0.00 | -4.79 | 0.00 | 0.00 | 0.00 | -27.93 | 0.00 | 0.00 | 0.00 | -7.75 | 0.00 | |
| % of Revenue | 53.63 | 52.91 | 44.35 | 43.70 | 43.91 | 41.98 | 29.06 | 27.73 | 27.37 | 24.97 | 22.54 | 21.96 | 20.67 | 22.72 | 15.81 | 14.86 | 14.41 | 13.61 | 12.28 | 12.51 |
| OpEx | 1,157 | 1,129 | 843 | 824 | 808 | 782 | 769 | 741 | 726 | 721 | 742 | 741 | 739 | 737 | 706 | 713 | 738 | 730 | 760 | 740 |
| Change (%) | -2.42 | -25.33 | -2.25 | -1.94 | -3.22 | -1.66 | -3.64 | -2.02 | -0.69 | 2.91 | -0.13 | -0.27 | -0.27 | -4.21 | 0.99 | 3.51 | -1.08 | 4.11 | -2.63 | |
| % of Revenue | 195.11 | 187.85 | 140.03 | 134.86 | 132.89 | 122.96 | 118.86 | 109.29 | 105.68 | 95.75 | 93.45 | 90.92 | 85.33 | 93.53 | 86.52 | 82.14 | 82.46 | 77.00 | 78.43 | 77.81 |
| Operating Income | -564 | -528 | -241 | -213 | -200 | -146 | -122 | -63 | -39 | 32 | 52 | 74 | 127 | 51 | 110 | 155 | 157 | 218 | 209 | 211 |
| Change (%) | -6.38 | -54.36 | -11.62 | -6.10 | -27.00 | -16.44 | -48.36 | -38.10 | -182.05 | 62.50 | 42.31 | 71.62 | -59.84 | 115.69 | 40.91 | 1.29 | 38.85 | -4.13 | 0.96 | |
| % of Revenue | -95.11 | -87.85 | -40.03 | -34.86 | -32.89 | -22.96 | -18.86 | -9.29 | -5.68 | 4.25 | 6.55 | 9.08 | 14.67 | 6.47 | 13.48 | 17.86 | 17.54 | 23.00 | 21.57 | 22.19 |
| Interest Expense | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||||||
| Change (%) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||||||||
| % of Revenue | -0.13 | -0.12 | -0.12 | -0.13 | -0.12 | -0.12 | -0.11 | -0.11 | -0.10 | -0.11 | ||||||||||
| Net Income | -644 | -634 | -318 | -299 | -287 | -258 | -258 | -206 | -195 | -91 | -289 | -220 | -127 | -193 | 186 | 226 | 231 | 299 | 249 | 258 |
| Change (%) | -1.55 | -49.84 | -5.97 | -4.01 | -10.10 | -0.00 | -20.16 | -5.34 | -53.33 | 217.58 | -23.88 | -42.27 | 51.97 | -196.37 | 21.51 | 2.21 | 29.44 | -16.72 | 3.61 | |
| % of Revenue | -108.60 | -105.49 | -52.82 | -48.94 | -47.20 | -40.57 | -39.88 | -30.38 | -28.38 | -12.08 | -36.40 | -26.99 | -14.67 | -24.49 | 22.79 | 26.04 | 25.81 | 31.54 | 25.70 | 27.13 |
Source: Capital IQ
